Akero Therapeutics Inc
1 day chart
Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.
Sign up and fund a new Wall St account and get a full U.S. share.
T&Cs apply
About AKRO
Akero Therapeutics, Inc. is a clinical-stage company. The Company is developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, including metabolic dysfunction-associated steatohepatitis (MASH), a disease without any approved therapies. Efruxifermin (EFX), is its lead product candidate for MASH, which is being evaluated in the ongoing phase IIb SYMMETRY, phase III SYNCHRONY Histology, and phase III SYNCHRONY real-world studies. The phase III SYNCHRONY program builds on the results of two phase IIb clinical trials, the HARMONY study in patients with pre-cirrhotic MASH and the SYMMETRY study in patients with cirrhosis due to MASH. EFX is an analog of fibroblast growth factor 21 (FGF21), which is an endogenously expressed hormone that protects against cellular stress and regulates metabolism of lipids, carbohydrates, and proteins throughout the body. EFX is designed to offer convenient once-weekly dosing.
Buy US stocks in Australia starting with AKRO. Open an account and start investing today!
$1.79B
-
0.00%
1
$26.18
$25.01
$0.00
$53.77
$11.25
Ready to start your investing journey with Stake?
Open an accountAKRO FAQs
- Find the right investing platform for you. To buy AKRO shares in Australia, you’ll need to open an account with an investing platform that offers the security. Try Stake, you can sign up in minutes.
- Fund your brokerage account. Once you are set up you can deposit into your account with different payment methods.
- Search for AKRO or Akero Therapeutics Inc. Find the stock by using the search function and go to the AKRO page.
- Place an order to buy AKRO. Press the ‘Buy’ button and choose an order type to place your trade. Depending on the order type, the trade will go through straight away or when a price target is hit.
- Monitor your portfolio. You’ve now purchased some AKRO shares. Stay on top of your portfolio and monitor its performance. You may be eligible for dividends and shareholder voting rights that affect your stock.
This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in AKRO
on Stake
Buy AKRO from US$3 brokerage
Invest in 9,500+ U.S. stocks and ETFs
Own a slice of AKRO from only US$10 with fractional shares
